Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this free, full length talk
Topics Covered
- What is convalescent plasma therapy
- Does this treatment confer long-lasting immunity?
- Mechanism of action of therapeutic antibodies
- Counterindications with plasma transfusions
- The need for lengthy clinical trials
- Preliminary assessment of convalescent plasma therapy in a clinical trial
- When might this treatment be approved, and how fast can it be delivered?
Biography
Manu Shankar-Hari is clinician-scientist in Intensive Care Medicine at Guy’s and St Thomas’ NHS Foundation Trust, London, and group lead for a translational research group at King’s College London.
Manu obtained his PhD from King’s College London, for his work on B cell abnormalities in sepsis and completed his Masters in epidemiology from the London School of Hygiene and Tropical Medicine. He holds the prestigious National Institute for Health Research (NIHR) Clinician Scientist Award in Intensive Care Medicine.
Manu’s translational research focuses on immunobiology, more specifically on lymphocyte abnormalities in sepsis-related critical illness and in sepsis survivors, as well as on clinical epidemiology, developing methods to enrich sepsis and ARDS populations on dominant mechanisms for immune therapy; Epidemiology and proximate determinants of Sepsis and ARDS related critical illness.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Shankar-Hari, M. (2020, June 15). Convalescent plasma therapy as a treatment for COVID-19 [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 8, 2024, from https://doi.org/10.69645/JSTU6449.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Manu Shankar-Hari has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Convalescent plasma therapy as a treatment for COVID-19
Other Talks in the Playlist: Interviews on Covid-19
Transcript
Quiz
Disclaimer: This quiz is intended for learning assessment purposes only and does not grant any certification or credit.
If you are interested in getting a certificate for watching the talk, follow the instructions in this talk's Accreditation Information (where available.)